Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Misonix (MSON) stocks in Canada

Learn how to easily invest in Misonix stocks.

Misonix is a medical devices business based in the US. Misonix stocks (MSON.US) are listed on the NASDAQ and all prices are listed in US Dollars. Misonix employs 281 staff and has a trailing 12-month revenue of around $74 million.

How to buy shares in Misonix

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MSON – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Misonix stock price (NASDAQ:MSON)

Use our graph to track the performance of MSON stocks over time.

Misonix shares at a glance

Information last updated 2022-01-16.
52-week range$12.43 - $26.99
50-day moving average $25.62
200-day moving average $22.03
Wall St. target price$28.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.84

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Misonix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Misonix price performance over time

Historical closes compared with the close of $N/A from 2021-11-16

1 week (2022-01-10) N/A
1 month (2021-12-17) N/A
3 months (2021-10-21) -100.00%
6 months (2021-07-21) -100.00%
1 year (2021-01-21) -100.00%
2 years (2020-01-21) -100.00%
3 years (2019-01-18) -100.00%
5 years (2017-01-20) -100.00%

Misonix financials

Revenue TTM $74 million
Gross profit TTM $52.6 million
Return on assets TTM -2.87%
Return on equity TTM -10.27%
Profit margin -19.55%
Book value $7.77
Market capitalisation $462.5 million

TTM: trailing 12 months

Misonix share dividends

We're not expecting Misonix to pay a dividend over the next 12 months.

Have Misonix's shares ever split?

Misonix's shares were split on a 3:2 basis on 20 October 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Misonix shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Misonix shares which in turn could have impacted Misonix's share price.

Misonix share price volatility

Over the last 12 months, Misonix's shares have ranged in value from as little as $12.43 up to $26.99. A popular way to gauge a stock's volatility is its "beta".

MSON.US volatility(beta: 1.35)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Misonix's is 1.3513. This would suggest that Misonix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Misonix overview

Misonix, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Misonix in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site